Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 880

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 880
---
6

AUTHORIZED REPRESENTATIVE Pursuant to the requirements of Section 6(a) of the Securities Act of 1933, the undersigned has signed this Registration Statement, solely in its capacity as the duly authorized representative of NLS Pharmaceutics Ltd. in the United States, on February27, 2025.

| PUGLISI & ASSOCIATES |     |                       |
| By:                  |     | /s/ Donald J. Puglisi |
| Name:                |     | Donald J. Puglisi     |
| Title:               |     | Managing Director     |

II-7